About ValenTx
ValenTx was a Healthcare company based in Carpinteria (United States) founded in 2002. It provides an adjustable endoluminal bypass sleeve for obesity treatment. It operates on a B2B model. ValenTx has raised $48.74 million across 5 funding rounds from investors including Medtronic, EDF Ventures and Kaiser Permanente Ventures. The company is recorded as dissolved. Its focus areas include Medical Devices, Obesity Treatment and Endoluminal Solutions. Its competitors include GI Windows and EndObetes; 1 of its 2 listed competitors has raised funding.
Company details
ValenTx, founded in 2002 in Carpinteria, United States, focuses on providing healthcare solutions, developing medical devices, obesity treatment, and endoluminal solutions. Provides an adjustable endoluminal bypass sleeve for obesity treatment. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
- Headquarters Carpinteria, United States
- SectorsHealthcare
- Website valentx.com
- Total Equity Funding$48.74M (USD)
in 5 rounds
- Latest Funding Round$1.97M (USD), Series B
Feb 2019
- InvestorsMedtronic
& 6 more
Funding Insights of ValenTx
ValenTx has successfully raised a total of $48.74M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $1.97 million completed in February 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $48.74M
- Total Rounds 5
- Last Round Series B — $1.97M
- First Round $7M
(May 2006)
- Investors Count 7
All 5 funding rounds of ValenTx with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2019 | $1.97M | Series B | – | – | – |
| Aug 2018 | $10.27M | Series B | – | – | – |
| Jul 2014 | $7.5M | Series B | – | – | – |
| Sep 2009 | $22M | Series B | – | SV Health Investors | |
| May 2006 | $7M | Series A | – | EDF Ventures |
7 investors in total: 7 institutional.
Investors in ValenTx
ValenTx has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include Medtronic, EDF Ventures and Kaiser Permanente Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage US tech and life science companies are invested in. | edfvc.com | Ann Arbor, United States | ||
Tech and Life Sciences focused corporate VC firm investing in the US | kpventures.com | Oakland, United States | ||
Venture capital fund focused on early-stage healthcare startups | svhealthinvestors.com | Boston, United States | ||
| affinitycapital.net | ||||
Comprehensive wealth management solutions are provided by Sapient Capital. | sapientcapital.com | Indianapolis, USA | ||
TGap Ventures is engaged in venture capital investments for startups. | tgapvcfunds.com | Kalamazoo, United States | ||
Medical equipment for treating over 30 chronic diseases is developed. | 1949 | medtronic.com | Minneapolis, United States |
Investor details for ValenTx
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of ValenTx
3 dated milestones of ValenTx across 17 years, from founding to its latest funding, stage changes and deals.
- Founded ValenTx is founded.
- Funding First funding round of $7.0M.
- Funding Latest funding round, Series B, of $2.0M.
Competitors of ValenTx
ValenTx has 2 listed competitors in our database, 1 of them funded. They include GI Windows and EndObetes.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| giwindows.com | 2012 | West Bridgewater, United States | $91.98M | 15 | Nonsurgical endoscopic devices for GI tract anastomoses are developed. | |
| endobetes.com | 2015 | New York, United States | Surgical access tool for obesity and diabetes treatment is developed. |
Detailed competitors of ValenTx
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Obesity
3 companies that operate in the same segment as ValenTx (Obesity) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Satiety induction through digestable gastric balloon introduced via a swallowed capsule | 2009 | Wellesley, Massachusetts, United States | USD 174.04 M | USD 32.11 M | 137 | |
Bioinformatics platform is provided for biomarkers and drug discovery. | 2015 | Vallejo, California, United States | USD 293.9 M | USD 8.99 M | 64 | |
Disease-modifying therapies for metabolic diseases are developed. | 2008 | Berkeley, California, United States | USD 385.52 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Valentx
Complete news archive for ValenTx
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ValenTx
ValenTx was founded in 2002 and raised its 1st funding round 4 years after it was founded.
ValenTx is headquartered in Carpinteria, United States. It is registered at Carpinteria, California, United States.
ValenTx is a funded company, having raised a total of $48.74M across 5 funding rounds to date. The company's 1st funding round was a Series A of $7M, raised on May 2006.
ValenTx, founded in 2002 in Carpinteria, United States, focuses on providing healthcare solutions, developing medical devices, obesity treatment, and endoluminal solutions. Provides an adjustable endoluminal bypass sleeve for obesity treatment. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
ValenTx's top competitors include GI Windows and EndObetes.
ValenTx has 7 investors. Key investors include Medtronic, EDF Ventures, Kaiser Permanente Ventures, SV Health Investors, and Affinity Capital Management.